Vectors Research Management’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$601K Sell
7,101
-427
-6% -$34.3K 0.16% 97
2026
Q1
$630K Buy
7,528
+33
+0.4% +$2.49K 0.18% 95
2025
Q4
$502K Buy
7,495
+81
+1% +$5.24K 0.15% 94
2025
Q3
$501K Buy
7,414
+89
+1% +$6.45K 0.16% 96
2025
Q2
$546K Sell
7,325
-91
-1% -$6.06K 0.19% 88
2025
Q1
$467K Buy
7,416
+27
+0.4% +$1.67K 0.16% 89
2024
Q4
$421K Sell
7,389
-1,263
-15% -$74.7K 0.14% 93
2024
Q3
$509K Sell
8,652
-65
-0.7% -$3.55K 0.15% 96
2024
Q2
$470K Sell
8,717
-414
-5% -$22.8K 0.14% 99
2024
Q1
$527K Sell
9,131
-561
-6% -$29K 0.15% 100
2023
Q4
$464K Sell
9,692
-290
-3% -$13.8K 0.13% 106
2023
Q3
$458K Sell
9,982
-103
-1% -$5.46K 0.15% 99
2023
Q2
$578K Sell
10,085
-1,001
-9% -$58.4K 0.16% 99
2023
Q1
$669K Buy
+11,086
New +$677K 0.17% 93
2022
Q3
Sell
-1,247
Closed -$68K 217
2022
Q2
$68K Hold
1,247
0.02% 199
2022
Q1
$72K Sell
1,247
-109
-8% -$5.57K 0.02% 197
2021
Q4
$64K Sell
1,356
-290
-18% -$13.2K 0.01% 237
2021
Q3
$69K Sell
1,646
-85
-5% -$3.68K 0.02% 215
2021
Q2
$77K Sell
1,731
-300
-15% -$13.9K 0.02% 207
2021
Q1
$95K Sell
2,031
-165
-8% -$7.3K 0.03% 186
2020
Q4
$85K Sell
2,196
-168
-7% -$6K 0.03% 169
2020
Q3
$61K Buy
2,364
+579
+32% +$16.3K 0.02% 169
2020
Q2
$48K Sell
1,785
-33
-2% -$859 0.02% 176
2020
Q1
$43K Sell
1,818
-376
-17% -$10.3K 0.02% 168
2019
Q4
$65K Buy
2,194
+1,339
+157% +$35.5K 0.03% 166
2019
Q3
$24K Sell
855
-100
-10% -$2.89K 0.01% 211
2019
Q2
$28K Buy
+955
New +$25.7K 0.02% 195

Other funds holding CTVA

Vectors Research Management's CTVA Position: Q2 2026 in Review

Vectors Research Management reduced its Corteva (CTVA) stake by 5.7% in Q2 2026, selling an estimated $34.3K and leaving 7,101 shares worth $601K. The position accounts for 0.16% of the portfolio, ranked #97.

Vectors Research Management first reported a position in CTVA in Q2 2019 and has held it in 27 quarters since. The position peaked at $669K in Q1 2023. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Vectors Research Management held 7,101 shares of Corteva worth $601K as of Q2 2026.
  • Vectors Research Management sold 427 Corteva shares in Q2 2026, an estimated $34.3K.
  • Corteva made up 0.16% of Vectors Research Management's portfolio in Q2 2026, its #97 holding.
  • Vectors Research Management first reported a position in Corteva in Q2 2019 and has held it in 27 quarters since.
  • Vectors Research Management's Corteva position peaked at $669K in Q1 2023.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.